Menten AI provides an advanced platform for peptide drug design, employing machine learning and first principles physics-based methods for molecular modeling. It overcomes the limitations of traditional drug design methodologies by generating its own data, leading to the efficient design of novel peptides with desirable drug properties. With capabilities that allow for a broader chemical space and significantly faster results than industry standards, Menten AI's platform has already validated multiple hit molecules for various drug targets, including a peptide for Covid-19. The focus is on peptide macrocycles and drug-conjugates to address hard-to-drug targets in a rapidly advancing sector of therapeutics.
• generative ai technology
• focus on peptide macrocycles and drug-conjugates
• high hit success rate (>50% in vitro)
• fast drug design turnaround (8 weeks)
• high sampling power
• first principles physics modeling
• machine learning-based peptide drug design
Generative AI platform for designing peptide therapeutics with high efficiency and accuracy.
Benefits:
Average Rating: 0.0
5 Stars:
0 Ratings
4 Stars:
0 Ratings
3 Stars:
0 Ratings
2 Stars:
0 Ratings
1 Star:
0 Ratings
No ratings available.
A federated AI framework that integrates decentralized data sources for AI development.
View DetailsTransform unstructured data into structured knowledge for accurate AI solutions.
View Details